178 related articles for article (PubMed ID: 34625949)
1. Efficacy of CO
Liu M; Li F; Zhou Y; Cao Y; Li S; Li Q
Int J Gynaecol Obstet; 2022 Aug; 158(2):241-251. PubMed ID: 34625949
[TBL] [Abstract][Full Text] [Related]
2. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
[TBL] [Abstract][Full Text] [Related]
3. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832
[TBL] [Abstract][Full Text] [Related]
4. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy.
Salvatore S; Nappi RE; Parma M; Chionna R; Lagona F; Zerbinati N; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
Climacteric; 2015 Apr; 18(2):219-25. PubMed ID: 25333211
[TBL] [Abstract][Full Text] [Related]
5. Fractional CO
Siliquini GP; Tuninetti V; Bounous VE; Bert F; Biglia N
Climacteric; 2017 Aug; 20(4):379-384. PubMed ID: 28503946
[TBL] [Abstract][Full Text] [Related]
6. Fractional Co
Alexiades MR
Lasers Surg Med; 2021 Feb; 53(2):185-198. PubMed ID: 32329093
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of non-ablative CO
Lami A; Alvisi S; Baldassarre M; Zanella S; Amati V; Seracchioli R; Meriggiola MC
Arch Gynecol Obstet; 2024 Apr; 309(4):1575-1583. PubMed ID: 38253692
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study.
Filippini M; Luvero D; Salvatore S; Pieralli A; Montera R; Plotti F; Candiani M; Angioli R
Menopause; 2020 Jan; 27(1):43-49. PubMed ID: 31794500
[TBL] [Abstract][Full Text] [Related]
9. Safety evaluation of fractional CO
Di Donato V; D'Oria O; Scudo M; Prata G; Fischetti M; Lecce F; Schiavi MC; Giannini A; Muzii L; Battaglia F; Monti M; Benedetti Panici P
Maturitas; 2020 May; 135():34-39. PubMed ID: 32252962
[TBL] [Abstract][Full Text] [Related]
10. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
[TBL] [Abstract][Full Text] [Related]
11. Treatment to External Labia and Vaginal Canal With CO2 Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women.
Samuels JB; Garcia MA
Aesthet Surg J; 2019 Jan; 39(1):83-93. PubMed ID: 29726916
[TBL] [Abstract][Full Text] [Related]
12. The Fractional CO
Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
[TBL] [Abstract][Full Text] [Related]
13. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser.
Perino A; Calligaro A; Forlani F; Tiberio C; Cucinella G; Svelato A; Saitta S; Calagna G
Maturitas; 2015 Mar; 80(3):296-301. PubMed ID: 25596815
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women.
Cruz VL; Steiner ML; Pompei LM; Strufaldi R; Fonseca FLA; Santiago LHS; Wajsfeld T; Fernandes CE
Menopause; 2018 Jan; 25(1):21-28. PubMed ID: 28763401
[TBL] [Abstract][Full Text] [Related]
15. CO
Salvatore S; Pitsouni E; Grigoriadis T; Zacharakis D; Pantaleo G; Candiani M; Athanasiou S
Climacteric; 2021 Apr; 24(2):187-193. PubMed ID: 33089713
[TBL] [Abstract][Full Text] [Related]
16. Vaginal CO
Pearson A; Booker A; Tio M; Marx G
Breast Cancer Res Treat; 2019 Nov; 178(1):135-140. PubMed ID: 31377895
[TBL] [Abstract][Full Text] [Related]
17. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.
De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE
Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
